Protara Therapeutics (TARA) Interest Coverage Ratio (2013 - 2014)
Protara Therapeutics (TARA) posted quarterly Interest Coverage Ratio of 2.22 for Q1 2026, up 33.61% year-over-year from 1.66 in Q1 2025, and up 95.85% quarter-over-quarter from 53.44 in Q4 2025.
Powered by 
Analysis
Protara Therapeutics (TARA) Interest Coverage Ratio (2013 - 2014) Analysis & Trends
Protara Therapeutics (TARA) has reported Interest Coverage Ratio for 14 consecutive years, with 2.22 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 33.61% year-over-year to 2.22; the TTM figure through Mar 2026 stood at 7.92 (up 34.92% YoY), while the FY2025 annual figure was 0.77, down 13.88% from the prior year.
- Interest Coverage Ratio grew to 2.22 in Q1 2026 per TARA's latest filing, from 53.44 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 2.22 in Q1 2026 and bottomed at 119.0 in Q4 2022.
- Historically, Interest Coverage Ratio has averaged 21.54 across 5 years, with a median of 7.01 in 2022.
- On a YoY basis, Interest Coverage Ratio climbed as much as 97.45% in 2022 and fell as far as 2565.33% in 2022.
- Protara Therapeutics' Interest Coverage Ratio stood at 119.0 in 2022, then soared by 61.18% to 46.2 in 2023, then advanced by 6.68% to 43.11 in 2024, then slipped by 23.97% to 53.44 in 2025, then jumped by 95.85% to 2.22 in 2026.
- Business Quant data shows TARA's Interest Coverage Ratio at 2.22 in Q1 2026, 53.44 in Q4 2025, and 2.92 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Protara Therapeutics | 241.28 Mn | 241.28 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2014 | -251.77 |
| Sep 30, 2014 | -13.40 |
| Jun 30, 2014 | -86.48 |
| Mar 31, 2014 | -2.33 |
| Dec 31, 2013 | -2.58 |
| Sep 30, 2013 | -11.19 |